$OCSL

Oaktree Specialty Lending Corp (OCSL): Results of Operations and Financial Condition

Oaktree Specialty Lending Corp (OCSL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d158058dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Oaktree Specialty Lending Corporation Announces Third Fiscal Quarter 2026 Financial Results LOS ANGELES, CA, August 5, 2026 - Oaktree Specialty Lending Corporation (NASDAQ: OCSL) (“Oaktree Specialty Lending” or the “Company

Original reporting
Published Aug 5, 2026, 10:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$OCSL
Neutral
medium confidence
Mentioned
$OCSL
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OCSLNeutralMed
01

Why it matters

The key tradable elements are the quarterly income metrics (GAAP and adjusted net investment income), NAV per share stability, leverage and liquidity snapshot, and the cash distribution schedule for Sept. 30, 2026.

02

Market read

Income and balance-sheet metrics plus a declared distribution can drive near-term positioning for specialty finance investors, especially around NAV durability and credit performance.

03

What to watch

The filing highlights restoring one non-accrual investment to accrual status; traders may need to monitor whether that improvement is durable into next quarter.

Relevance 7/10Novelty 7/10Timing: filed pre-market today, with distribution payable Sept. 30, 2026

Background

This is an SEC Form 8-K with Exhibit 99.1 reporting OCSL’s third fiscal quarter ended June 30, 2026 financial results and declared distributions.

Company-level read

Ticker impact

$OCSLNeutralMedium confidence
Context

OCSL reported Q3 FY2026 results, including NAV per share of $15.70 and declared cash distributions of $0.30 per share plus $0.03 supplemental.

Expected impact

Likely modest, with focus on whether lower investment income and stable NAV support the distribution and credit-quality narrative.

Evidence & confidence

The filing provides concrete quarterly datapoints (investment income, GAAP/adjusted net investment income, NAV, leverage, liquidity) and a forward-dated distribution payable Sept. 30, 2026, but it does not include guidance or a major surprise event.

Market effects

BDC/specialty lender peers may see read-across on non-accrual reduction, leverage discipline, and liquidity levels.

No clear regional catalyst beyond US-listed specialty finance sentiment.

Limited, as the disclosure is company-specific and not tied to global macro shocks.

Counterpoint

Stable NAV may mask underlying earnings pressure from lower average portfolio balance and non-recurring income declines.

Key entities

  • Oaktree Specialty Lending Corporation

    Subject of the 8-K, reporting Q3 FY2026 results, NAV, leverage/liquidity, and declared cash distributions.

  • Armen Panossian

    CEO and Co-Chief Investment Officer quoted on progress reducing non-accrual investments and maintaining conservative leverage.

Related articles

$CPKMedAI 8/10

Chesapeake Utilities (CPK) Q2 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q2 2026 adjusted net income of $25.4 million, up 5% year over year, and adjusted EPS of $1.05. Management raised 2026 capital guidance to $550 million to $600 million and expects 2028 EPS of $7.75 to $8.00. It also discussed the $1.2 billion Florida Energy Pathway project and reaffirmed efficiency and dividend plans.

$QNSTHighAI 9/10

QuinStreet (QNST) Q4 2026 Earnings Call Transcript

QuinStreet (QNST) reported Q4 FY2026 revenue of $373.9M, up 43% y/y, and full-year revenue of $1.3B, up 18% y/y, driven by Financial Services and Home Services. Adjusted EBITDA rose to $41.4M (11.1% margin). Non-GAAP EPS was $0.50 in Q4. Q1 2027 revenue guidance is $370M-$380M.

$AVPTMedAI 9/10

AvePoint (AVPT) Q2 2026 Earnings Call Transcript

AvePoint (AVPT) reported Q2 2026 revenue of $124.5M, up 22% YoY, with SaaS revenue $98.5M (79% of total). Total ARR was $465.1M (+27%), net new ARR $29.9M, and GAAP operating margin 8.2%. Full-year guidance: ARR $522.1M-$528.1M and revenue $508.5M-$512.5M. The company also spent $50M on share repurchases in Q2.

$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.

$ALRMMedAI 9/10

Alarm.com (ALRM) Q2 2026 Earnings Call Transcript

Alarm.com (ALRM) reported Q2 2026 results. SaaS and license revenue was $188.8 million, up 11.1% YoY and above guidance midpoint. Total revenue rose 9.2% to $277.7 million. Non-GAAP adjusted EBITDA was $57.7 million, up 15.7%, and adjusted EPS was $0.77. Full-year guidance was raised for SaaS, total revenue, and adjusted EBITDA.

$INTCMedAI 8/10

A $20 Billion Reason Why Intel Stock Is in Focus

Intel expects Q3 revenue of $15.8B to $16.8B versus about $15.1B consensus, and adjusted EPS of $0.38 versus $0.27 consensus. Intel raised 2026 capital spending to over $20B and plans more in 2027. It is investing in Ireland foundry operations and signed 10 server CPU customer agreements. Analysts are mixed on INTC targets.